{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:52:39Z","timestamp":1765738359599,"version":"3.48.0"},"reference-count":17,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Allied Medical K.K."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,4]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is a major health challenge imposing substantial economic and health burdens worldwide. This study compared treatment outcomes and costs between cost-intensive and non-cost-intensive pharmacotherapies, defined by prescribing intervals and the type of drugs, using electronic health record (EHR) data from multiple healthcare facilities, focusing on the type of antihypertensive drug and prescribing patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective cohort study. A mixed-effects Cox proportional hazards model was used to investigate the association between cardiovascular events and healthcare resource use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>EHRs from 34 primary care facilities in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients prescribed either angiotensin receptor blockers (ARBs) alone or calcium channel blockers (CCBs) alone were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 6629 person-years of follow-up, 71 events were observed. Model diagnostics confirmed the proportional hazards assumption and substantial inter-clinic heterogeneity. The type of drug (ARBs or CCBs) had no statistically significant impact on the incidence of cardiovascular events (HR 0.999, 95%\u2009CI 0.603 to 1.655). Similarly, shorter prescribing intervals (less than 36 days) were not significantly associated with the outcome (HR 1.724, 95%\u2009CI 0.906 to 3.279). The mean annual medical cost per patient for the cost-intensive (ARB with short prescribing intervals) and non-cost-intensive (CCB with long prescribing intervals) groups was Japanese yen (JPY) 137 023 and JPY 85 911, respectively. Sensitivity analysis using different time windows yielded similar results, confirming the robustness of the findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>No apparent reduction in cardiovascular events associated with the use of ARBs or shorter prescribing intervals was observed despite the elevated cost caused by intensive pharmacotherapy and frequent clinic visits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097305","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:11:07Z","timestamp":1752657067000},"page":"e097305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and economic impact of cost-intensive vs non-cost-intensive antihypertensive therapies: a retrospective study using real-world data from Japan"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-3822","authenticated-orcid":false,"given":"Hiroshi","family":"Yoshihara","sequence":"first","affiliation":[{"name":"Department of Health Economics and Outcomes Research, The University of Tokyo, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, The University of Tokyo, Bunkyo-ku, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Tonoike","sequence":"additional","affiliation":[{"name":"Allied Medical KK, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Ohno","sequence":"additional","affiliation":[{"name":"Allied Medical KK, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Nishiuchi","sequence":"additional","affiliation":[{"name":"Allied Medical KK, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6916","authenticated-orcid":false,"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Outcomes Research, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025121410481081000_15.7.e097305.1","unstructured":"World Health Organization . A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013. 2013."},{"key":"2025121410481081000_15.7.e097305.2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.119.14240"},{"key":"2025121410481081000_15.7.e097305.3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.03081.x"},{"key":"2025121410481081000_15.7.e097305.4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mcna.2016.08.001","article-title":"The Kidney in Hypertension","volume":"101","author":"Sternlicht","year":"2017","journal-title":"Med Clin North Am"},{"key":"2025121410481081000_15.7.e097305.5","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-014-0447-7","article-title":"Hypertension as a risk factor for heart failure","volume":"16","author":"Kannan","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"2025121410481081000_15.7.e097305.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9"},{"key":"2025121410481081000_15.7.e097305.7","unstructured":"Ministry of Health Labour and Welfare, Japan . Summary of the medical health expenditure in 2019, Available: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-iryohi\/19\/index.html"},{"key":"2025121410481081000_15.7.e097305.8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41440-020-00580-3","article-title":"Big data and real-world data-based medicine in the management of hypertension","volume":"44","author":"Okada","year":"2021","journal-title":"Hypertens Res"},{"key":"2025121410481081000_15.7.e097305.9","doi-asserted-by":"crossref","DOI":"10.1186\/s40545-021-00385-w","article-title":"Estimating proportion of days covered (PDC) using real-world online medicine suppliers\u2019 datasets","volume":"14","author":"Prieto-Merino","year":"2021","journal-title":"J Pharm Policy Pract"},{"key":"2025121410481081000_15.7.e097305.10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2147\/CLEP.S265619","article-title":"Validity of Acute Cardiovascular Outcome Diagnoses Recorded in European Electronic Health Records: A Systematic Review","volume":"12","author":"Davidson","year":"2020","journal-title":"Clin Epidemiol"},{"key":"2025121410481081000_15.7.e097305.11","first-page":"279","article-title":"DRG\/PPS and DPC\/PDPS as Prospective Payment Systems","volume":"55","author":"Ishii","year":"2012","journal-title":"Japan Med Assoc J"},{"key":"2025121410481081000_15.7.e097305.12","doi-asserted-by":"publisher","DOI":"10.1111\/insr.12214"},{"key":"2025121410481081000_15.7.e097305.13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jhh.2016.46","article-title":"High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis","volume":"31","author":"He","year":"2017","journal-title":"J Hum Hypertens"},{"key":"2025121410481081000_15.7.e097305.14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jch.13096","article-title":"The importance of frequent return visits and hypertension control among US young adults: a multidisciplinary group practice observational study","volume":"19","author":"King","year":"2017","journal-title":"J of Clinical Hypertension"},{"key":"2025121410481081000_15.7.e097305.15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1524-6175.2005.04371.x","article-title":"Visit Frequency and Hypertension","volume":"7","author":"Guthmann","year":"2005","journal-title":"J of Clinical Hypertension"},{"key":"2025121410481081000_15.7.e097305.16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/13696998.2020.1716775","article-title":"Health technology assessment in Japan: a work in progress","volume":"23","author":"Kamae","year":"2020","journal-title":"J Med Econ"},{"key":"2025121410481081000_15.7.e097305.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-018-0499-5","article-title":"Analysis of randomised trials with long-term follow-up","volume":"18","author":"Herbert","year":"2018","journal-title":"BMC Med Res Methodol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:48:21Z","timestamp":1765738101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2024-097305"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097305","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}